tiprankstipranks
Trending News
More News >
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market

BioCryst (BCRX) Ratios

Compare
2,678 Followers

BioCryst Ratios

BCRX's free cash flow for Q4 2025 was $0.98. For the 2025 fiscal year, BCRX's free cash flow was decreased by $ and operating cash flow was $0.64. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.06 2.06 2.63 3.31 4.90
Quick Ratio
2.03 2.03 2.58 3.12 4.63
Cash Ratio
0.46 0.46 0.65 0.74 2.89
Solvency Ratio
0.42 0.42 -0.09 -0.23 -0.29
Operating Cash Flow Ratio
1.69 1.68 -0.32 -0.63 -1.53
Short-Term Operating Cash Flow Coverage
8.26 8.23 -1.47 0.00 0.00
Net Current Asset Value
$ -228.97M$ -228.97M$ -544.39M$ -476.52M$ -328.10M
Leverage Ratios
Debt-to-Assets Ratio
0.93 0.93 1.72 1.60 1.35
Debt-to-Equity Ratio
-4.01 -4.01 -1.77 -1.81 -2.52
Debt-to-Capital Ratio
1.33 1.33 2.30 2.23 1.66
Long-Term Debt-to-Capital Ratio
1.39 1.39 2.49 2.28 1.67
Financial Leverage Ratio
-4.32 -4.32 -1.03 -1.13 -1.87
Debt Service Coverage Ratio
2.92 2.89 0.08 -1.08 -1.48
Interest Coverage Ratio
4.32 4.32 -0.03 -0.96 -1.50
Debt to Market Cap
0.23 0.29 0.53 0.70 0.34
Interest Debt Per Share
2.64 2.65 4.55 4.86 4.52
Net Debt to EBITDA
1.10 1.11 57.50 -6.14 -3.04
Profitability Margins
Gross Profit Margin
97.74%97.82%97.23%98.59%97.57%
EBIT Margin
39.58%39.58%2.57%-35.60%-53.65%
EBITDA Margin
40.16%39.74%2.84%-35.10%-53.12%
Operating Profit Margin
38.98%38.98%-0.56%-31.29%-54.81%
Pretax Profit Margin
30.56%30.56%-19.29%-68.26%-90.24%
Net Profit Margin
30.16%30.16%-19.72%-68.36%-91.24%
Continuous Operations Profit Margin
30.16%30.16%-19.72%-68.36%-91.24%
Net Income Per EBT
98.68%98.68%102.22%100.14%101.12%
EBT Per EBIT
78.42%78.42%3419.35%218.14%164.64%
Return on Assets (ROA)
51.32%51.32%-18.12%-43.82%-44.93%
Return on Equity (ROE)
-76.45%-221.45%18.68%49.73%83.88%
Return on Capital Employed (ROCE)
107.20%107.20%-0.77%-28.26%-33.39%
Return on Invested Capital (ROIC)
93.94%93.94%-0.70%-28.06%-33.22%
Return on Tangible Assets
51.32%51.32%-18.12%-43.82%-44.93%
Earnings Yield
12.75%16.12%-5.72%-19.68%-11.58%
Efficiency Ratios
Receivables Turnover
8.19 8.19 5.70 5.82 5.35
Payables Turnover
1.25 1.21 1.07 0.22 0.46
Inventory Turnover
3.67 3.53 1.54 0.16 0.24
Fixed Asset Turnover
46.08 46.08 22.78 15.85 31.43
Asset Turnover
1.70 1.70 0.92 0.64 0.49
Working Capital Turnover Ratio
4.68 3.72 1.48 0.88 0.62
Cash Conversion Cycle
-147.63 -154.97 -39.96 672.75 797.58
Days of Sales Outstanding
44.57 44.57 64.03 62.72 68.19
Days of Inventory Outstanding
99.49 103.29 236.42 2.25K 1.52K
Days of Payables Outstanding
291.68 302.83 340.41 1.64K 794.65
Operating Cycle
144.06 147.86 300.46 2.31K 1.59K
Cash Flow Ratios
Operating Cash Flow Per Share
1.57 1.57 -0.25 -0.50 -0.87
Free Cash Flow Per Share
1.56 1.56 -0.26 -0.51 -0.88
CapEx Per Share
0.01 0.01 <0.01 0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.99 0.99 1.02 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
134.09 133.66 -46.28 -43.88 -119.80
Capital Expenditure Coverage Ratio
134.09 133.66 -46.28 -43.88 -119.80
Operating Cash Flow Coverage Ratio
0.69 0.69 -0.06 -0.12 -0.22
Operating Cash Flow to Sales Ratio
0.38 0.38 -0.12 -0.29 -0.60
Free Cash Flow Yield
15.95%20.00%-3.42%-8.45%-7.65%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
7.84 6.20 -17.49 -5.08 -8.64
Price-to-Sales (P/S) Ratio
2.35 1.87 3.45 3.47 7.88
Price-to-Book (P/B) Ratio
-17.37 -13.74 -3.27 -2.53 -7.24
Price-to-Free Cash Flow (P/FCF) Ratio
6.27 5.00 -29.25 -11.83 -13.08
Price-to-Operating Cash Flow Ratio
6.25 4.96 -29.88 -12.10 -13.19
Price-to-Earnings Growth (PEG) Ratio
<0.01 -0.02 0.28 0.45 -0.30
Price-to-Fair Value
-17.37 -13.74 -3.27 -2.53 -7.24
Enterprise Value Multiple
6.96 5.82 178.86 -16.04 -17.87
Enterprise Value
2.45B 2.02B 2.29B 1.87B 2.57B
EV to EBITDA
6.96 5.82 178.86 -16.04 -17.87
EV to Sales
2.80 2.31 5.08 5.63 9.49
EV to Free Cash Flow
7.45 6.18 -43.11 -19.17 -15.75
EV to Operating Cash Flow
7.39 6.14 -44.04 -19.61 -15.88
Tangible Book Value Per Share
-0.56 -0.57 -2.30 -2.37 -1.58
Shareholders’ Equity Per Share
-0.56 -0.57 -2.30 -2.37 -1.58
Tax and Other Ratios
Effective Tax Rate
0.01 0.01 -0.02 >-0.01 -0.01
Revenue Per Share
4.15 4.17 2.18 1.72 1.46
Net Income Per Share
1.25 1.26 -0.43 -1.18 -1.33
Tax Burden
0.99 0.99 1.02 1.00 1.01
Interest Burden
0.77 0.77 -7.52 1.92 1.68
Research & Development to Revenue
0.19 0.19 0.39 0.65 0.94
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.13 0.00 0.15 0.17 0.17
Income Quality
0.87 1.25 0.59 0.42 0.65
Currency in USD